The affected products are 10-millilter vials of testosterone injections with a strength of 200 milligrams/millileters. The recall, which is voluntary, was issued due to the presence of particulate matter in the vials.
The injections are used as a replacement therapy in males who are testosterone-deficient.
More articles on pharmacy:
Allergan sues Pfizer over costs related to opioid lawsuits
Teva’s revenue drops 18% in Q2
Who knew? There’s a trophy for ‘most hated’ pharma chief: 10 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
